Agreement between region-of-interest- and parametric map-based hepatic proton density fat fraction estimation in adults with chronic liver disease

Abdominal Radiology

Volumn 42, Issue 3, 2017, Pages 833-841

  Manning, Paul M ^a   Hamilton, Gavin ^a   Wang, Kang ^a   Park, Chulhyun ^a   Hooker, Jonathan C ^a   Wolfson, Tanya ^b   Gamst, Anthony ^b   Haufe, William M ^a   Schlein, Alex N ^a   Middleton, Michael S ^a   Sirlin, Claude B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Analysis methods; Fat quantification; Hepatic steatosis; MRI; PDFF; Proton density fat fraction; QIB; Quantitative imaging biomarker

Indexed keywords

BIOLOGICAL MARKER; GADOXETIC ACID; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; FATTY LIVER; FEMALE; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HEPATOBILIARY PARAMETERS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; METASTATIC BREAST CANCER; METASTATIC COLORECTAL CANCER; METASTATIC MELANOMA; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON DENSITY FAT FRACTION; QUANTITATIVE ANALYSIS; SIGNAL NOISE RATIO; ALGORITHM; CHRONIC DISEASE; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; MIDDLE AGED; PROCEDURES;

ADULT; AGED; ALGORITHMS; CHRONIC DISEASE; CONTRAST MEDIA; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84989184366     PISSN: 2366004X     EISSN: 23660058     Source Type: Journal    
DOI: 10.1007/s00261-016-0925-2     Document Type: Article

References (20)

1. Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34(4):729–749
2. Tang A, Tan J, Sun M, et al. (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267(2):422–431
3. Tang A, Desai A, Hamilton G, et al. (2015) Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274(2):416–425
4. Yokoo T, Bydder M, Hamilton G, et al. (2009) Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 251(1):67–76
5. Yokoo T, Shiehmorteza M, Hamilton G, et al. (2011) Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 258(3):749–759
6. Negrete LM, Middleton MS, Clark L, et al. (2014) Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects. J Magn Reson Imaging 39(5):1265–1271
7. Kang GH, Cruite I, Shiehmorteza M, et al. (2011) Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. J Magn Reson Imaging 34(4):928–934
8. Mashhood A, Railkar R, Yokoo T, et al. (2013) Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging. J Magn Reson Imaging 37(6):1359–1370
9. Artz NS, Haufe WM, Hooker CA, et al. (2015) Reproducibility of MR-based liver fat quantification across field strength: same-day comparison between 1.5 T and 3 T in obese subjects. J Magn Reson Imaging 42(3):811–817
10. Loomba R, Sirlin CB, Ang B, et al. (2015) Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel MRI and MRE in a randomized trial (MOZART Trial). Hepatology 61(4):1239–1250
11. Hamilton G, Yokoo T, Bydder M, et al. (2011) In vivo characterization of the liver fat (1)H MR spectrum. NMR Biomed 24(7):784–790
12. Yu H, Shimakawa A, McKenzie CA, et al. (2008) Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med 60(5):1122–1134
13. Arras KO (1998) An introduction to error propagation: derivation, meaning and examples of Cy = Fx Cx Fx′.
14. Levin YS, Yokoo T, Wolfson T, et al. (2014) Effect of echo-sampling strategy on the accuracy of out-of-phase and in-phase multiecho gradient-echo MRI hepatic fat fraction estimation. J Magn Reson Imaging 39(3):567–575
15. Bonekamp S, Tang A, Mashhood A, et al. (2014) Spatial distribution of MRI-determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease. J Magn Reson Imaging 39(6):1525–1532
16. Yokoo T, Collins JM, Hanna RF, et al. (2008) Effects of intravenous gadolinium administration and flip angle on the assessment of liver fat signal fraction with opposed-phase and in-phase imaging. J Magn Reson Imaging 28(1):246–251
17. Bydder M, Yokoo T, Hamilton G, et al. (2008) Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 26(3):347–359
18. Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB (2007) Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med 58(2):354–364
19. Henkelman RM (1985) Measurement of signal intensities in the presence of noise in MR images. Med Phys 12(2):232–233
20. Reeder SB, Hu HH, Sirlin CB (2012) Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging 36(5):1011–1014